
201 - 500 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Crinetics Pharmaceuticals is a biotechnology company that develops innovative therapies for endocrine diseases. The company is focused on addressing unmet medical needs by creating treatments for conditions such as acromegaly, carcinoid syndrome, ACTH-dependent Cushing’s syndrome, congenital adrenal hyperplasia, and other endocrine disorders. Crinetics is committed to improving the quality of life for patients through cutting-edge science and robust clinical trials. Their pipeline includes promising candidates like paltusotine, which has been accepted by the U. S. Food and Drug Administration for the treatment of adult patients with acromegaly. The company collaborates with healthcare practitioners and stakeholders to ensure that their therapies address real-life problems effectively and build value for investors by entering market niches with significant needs.
🔥 20 hours ago
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Crinetics Pharmaceuticals is a biotechnology company that develops innovative therapies for endocrine diseases. The company is focused on addressing unmet medical needs by creating treatments for conditions such as acromegaly, carcinoid syndrome, ACTH-dependent Cushing’s syndrome, congenital adrenal hyperplasia, and other endocrine disorders. Crinetics is committed to improving the quality of life for patients through cutting-edge science and robust clinical trials. Their pipeline includes promising candidates like paltusotine, which has been accepted by the U. S. Food and Drug Administration for the treatment of adult patients with acromegaly. The company collaborates with healthcare practitioners and stakeholders to ensure that their therapies address real-life problems effectively and build value for investors by entering market niches with significant needs.
• Own the acromegaly HEOR/RWE evidence strategy across the product lifecycle • Serve as the primary HEOR/RWE point of contact for acromegaly franchise stakeholders • Translate franchise evidence questions into prioritized, executable plans • Contribute the acromegaly HEOR/RWE narrative to integrated evidence plans, value dossiers, AMCP and global value dossiers, and HTA submissions • Partner with Market Access on payer value propositions, budget impact, and access strategy for acromegaly • Align acromegaly evidence generation to launch, access, and lifecycle milestones • Represent the acromegaly evidence story to KOLs, payers, HTA bodies, and at scientific congresses • Support the Senior Director in maintaining a coherent franchise value story • Monitor the competitive and treatment landscape in acromegaly and translate implications into evidence strategy • Ensure compliance with corporate policies and US healthcare laws governing evidence generation and communication
• Advanced degree in health economics, outcomes research, epidemiology, health services research, public health, or related discipline (PhD, MD, PharmD, MPH, MSc) • Minimum of 10+ years of relevant pharmaceutical, biotech, or HEOR consulting experience • Minimum of 8+ years of supervisory experience • Demonstrated ability to define and drive a therapeutic-area evidence strategy across the product lifecycle (pre-launch through lifecycle management) • Strong stakeholder management and influencing skills • Working knowledge across the HEOR/RWE toolkit — RWE, PRO/COA, economic modeling, and HTA evidence requirements • Experience contributing HEOR evidence to value dossiers and HTA/payer submissions • Excellent communication and interpersonal skills • Ability to lead, collaborate, and influence cross-functional teams • Ability to ensure compliance with corporate policies and procedures, as well as US healthcare laws and regulations • Flexible, adaptable, and able to operate effectively in ambiguity within a fast-scaling pipeline
• Discretionary annual target bonus • Stock options • ESPP • 401k match • Top-notch health insurance plans for employees (and their families) • 20 days of PTO • 10 paid holidays • Winter company shutdown
Apply Now🔥 20 hours ago
Senior Director overseeing Data Center construction projects at Iron Mountain. Leading project execution and managing construction teams to meet high uptime standards.
🕒 Yesterday
Senior Director of Strategic Accounts managing large client relationships for OneStudyTeam's innovative SaaS platform, addressing complex sales in the Life Sciences sector.
🕒 Yesterday
201 - 500
Develop and execute national account strategies for healthcare customers at Cosette Pharmaceuticals. Leading engagement and account strategy development with key institutional customers.
🕒 Yesterday
11 - 50
Senior Director responsible for optimizing various aspects of commercial operations at DwyerOmega. Focus on strategies to improve sales effectiveness, customer engagement, and commercial process efficiency.
🕒 Yesterday
Sr. Director of Digital Transformation leading eCommerce for Lovesac, overseeing technical roadmaps and customer-facing platforms. Driving business strategy through eComm integration and AI.